Skip to main content

Dr. David A. Wohl, M.D.

Infectious Disease (Infectious Disease Physician)

  • Medicare participating

At a glance

Years since graduation
35
In the NPI registry since
2006
Medicare patients seen, 2024
53

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 1991Medical school: Rowan University School of Osteopathic Medicine
  • 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Infectious Disease Physician primary
    NC license 9400396

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Infectious Disease per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
53
Services billed
187
Patients’ average age
67
Most frequent Medicare services, 2023
ServiceTimesPatients
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes5514
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes5114
Established patient office or other outpatient visit, 40-54 minutes1713
Established patient office or other outpatient visit, 30-39 minutes1614
Insertion of needle into vein for collection of blood sample1614

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Most prescribed drugs, Medicare Part D 2024
DrugPrescriptions
Biktarvy (bictegrav/emtricit/tenofov ala)253
Tivicay (dolutegravir sodium)183
Descovy (emtricitabine/tenofov alafenam)171
Atorvastatin Calcium
Other prescribers in Chapel Hill, NC
119
Amlodipine Besylate
Other prescribers in Chapel Hill, NC
67
Gabapentin
Other prescribers in Chapel Hill, NC
61
Oxycodone Hcl
Other prescribers in Chapel Hill, NC
49
Methadone Hcl
Other prescribers in Chapel Hill, NC
46
Enalapril Maleate
Other prescribers in Chapel Hill, NC
45
Dovato (dolutegravir sodium/lamivudine)42

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 5 companies reported 78 payments worth $76,334 in total to this clinician.

By company
Merck Sharp & Dohme LLC$25,240
Gilead Sciences, Inc.$23,765
Viiv Healthcare Company$19,145
Theratechnologies Inc.$5,002
Shionogi Inc$3,182
By type
Consulting Fee$59,510
Travel and Lodging$7,509
Honoraria$3,960
Compensation for services other than consulting (speaking, faculty)$3,182
Food and Beverage$2,173

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Oct 15, 2025Merck Sharp & Dohme LLC
Oct 15, 2025
Consulting Fee$10,440
Apr 16, 2025Gilead Sciences, Inc.
Apr 16, 2025
Consulting Fee
Company’s description;3978884;GTF;10018958
$8,920
Apr 2, 2025Viiv Healthcare Company
Apr 2, 2025
Consulting Fee$6,500
Apr 2, 2025Viiv Healthcare Company
Apr 2, 2025
Consulting Fee$6,500
Dec 8, 2025Gilead Sciences, Inc.
Dec 8, 2025
Consulting Fee
Sunlenca · HIV
Company’s description;4288216;GTF;10018958
$5,950
Feb 24, 2025Merck Sharp & Dohme LLC
Feb 24, 2025
Consulting Fee$5,220
Nov 24, 2025Merck Sharp & Dohme LLC
Nov 24, 2025
Consulting Fee$4,640
Dec 15, 2025Theratechnologies Inc.
Dec 15, 2025
Honoraria
EGRIFTA · HIV
$3,960
Aug 5, 2025Viiv Healthcare Company
Aug 5, 2025
Consulting Fee$3,900
Feb 17, 2025Shionogi Inc
Feb 17, 2025
Compensation for services other than consulting (speaking, faculty)
S-217622 · Infections and Infectious Diseases
$3,182
All 43 payments other than meals, newest first
All payments other than meals
DateCompanyWhat it was forAmount
Dec 15, 2025Theratechnologies Inc.
Dec 15, 2025
Honoraria
EGRIFTA · HIV
$3,960
Dec 15, 2025Theratechnologies Inc.
Dec 15, 2025
Travel and Lodging
EGRIFTA · HIV · travel to Dallas, TX
$64.00
Dec 8, 2025Gilead Sciences, Inc.
Dec 8, 2025
Consulting Fee
Sunlenca · HIV
Company’s description;4288216;GTF;10018958
$5,950
Nov 24, 2025Merck Sharp & Dohme LLC
Nov 24, 2025
Consulting Fee$4,640
Nov 24, 2025Merck Sharp & Dohme LLC
Nov 24, 2025
Travel and Lodging
travel to Philadelphia, PA
$150
Nov 18, 2025Merck Sharp & Dohme LLC
Nov 18, 2025
Travel and Lodging
PIFELTRO · INFECTIOUS DISEASE · travel to Philadelphia, PA · in-kind
$411
Nov 17, 2025Merck Sharp & Dohme LLC
Nov 17, 2025
Travel and Lodging
PIFELTRO · INFECTIOUS DISEASE · travel to Philadelphia, PA · in-kind
$709
Nov 17, 2025Merck Sharp & Dohme LLC
Nov 17, 2025
Travel and Lodging
PIFELTRO · INFECTIOUS DISEASE · travel to Philadelphia, PA · in-kind
$313
Nov 14, 2025Gilead Sciences, Inc.
Nov 14, 2025
Travel and Lodging
Sunlenca · HIV · travel to Boston, MA · in-kind
Company’s description;4288250;GTF;10018958
$313
Nov 14, 2025Gilead Sciences, Inc.
Nov 14, 2025
Travel and Lodging
Sunlenca · HIV · travel to Boston, MA · in-kind
Company’s description;4288109;GTF;10018958
$58.30
Nov 13, 2025Gilead Sciences, Inc.
Nov 13, 2025
Travel and Lodging
Sunlenca · HIV · travel to Boston, MA · in-kind
Company’s description;4288185;GTF;10018958
$367
Nov 13, 2025Gilead Sciences, Inc.
Nov 13, 2025
Travel and Lodging
Sunlenca · HIV · travel to Boston, MA · in-kind
Company’s description;4288254;GTF;10018958
$160
Nov 13, 2025Gilead Sciences, Inc.
Nov 13, 2025
Travel and Lodging
Sunlenca · HIV · travel to Boston, MA
Company’s description;4288189;GTF;10018958
$64.00
Nov 6, 2025Theratechnologies Inc.
Nov 6, 2025
Travel and Lodging
EGRIFTA · HIV · travel to Dallas, TX · in-kind
$239
Nov 3, 2025Viiv Healthcare Company
Nov 3, 2025
Travel and Lodging
travel to Chicago, IL · in-kind
$250
Oct 20, 2025Theratechnologies Inc.
Oct 20, 2025
Travel and Lodging
EGRIFTA · HIV · travel to Dallas, TX · in-kind
$534
Oct 15, 2025Merck Sharp & Dohme LLC
Oct 15, 2025
Consulting Fee$10,440
Oct 15, 2025Gilead Sciences, Inc.
Oct 15, 2025
Consulting Fee
Biktarvy · HIV
Company’s description;4285347;VEM US;10018958
$2,850
Oct 15, 2025Merck Sharp & Dohme LLC
Oct 15, 2025
Travel and Lodging
travel to Philadelphia, PA
$150
Oct 9, 2025Viiv Healthcare Company
Oct 9, 2025
Travel and Lodging
travel to Chicago, IL · in-kind
$248
Oct 9, 2025Viiv Healthcare Company
Oct 9, 2025
Travel and Lodging
travel to Chicago, IL · in-kind
$31.41
Sep 29, 2025Merck Sharp & Dohme LLC
Sep 29, 2025
Travel and Lodging
INFECTIOUS DISEASE · travel to Philadelphia, PA · in-kind
$260
Sep 28, 2025Merck Sharp & Dohme LLC
Sep 28, 2025
Travel and Lodging
INFECTIOUS DISEASE · travel to Philadelphia, PA · in-kind
$681
Sep 28, 2025Merck Sharp & Dohme LLC
Sep 28, 2025
Travel and Lodging
INFECTIOUS DISEASE · travel to Philadelphia, PA · in-kind
$275
Sep 28, 2025Merck Sharp & Dohme LLC
Sep 28, 2025
Travel and Lodging
INFECTIOUS DISEASE · travel to Philadelphia, PA · in-kind
$260
Sep 28, 2025Merck Sharp & Dohme LLC
Sep 28, 2025
Travel and Lodging
INFECTIOUS DISEASE · travel to Philadelphia, PA · in-kind
$171
Aug 5, 2025Viiv Healthcare Company
Aug 5, 2025
Consulting Fee$3,900
Apr 16, 2025Gilead Sciences, Inc.
Apr 16, 2025
Consulting Fee
Company’s description;3978884;GTF;10018958
$8,920
Apr 2, 2025Viiv Healthcare Company
Apr 2, 2025
Consulting Fee$6,500
Apr 2, 2025Viiv Healthcare Company
Apr 2, 2025
Consulting Fee$6,500
Apr 2, 2025Viiv Healthcare Company
Apr 2, 2025
Travel and Lodging
travel to Chicago, IL · in-kind
$205
Mar 31, 2025Gilead Sciences, Inc.
Mar 31, 2025
Consulting Fee
Company’s description;4147546;VEM US;10018958
$1,740
Mar 12, 2025Viiv Healthcare Company
Mar 12, 2025
Travel and Lodging
travel to San Francisco, CA · in-kind
$287
Mar 6, 2025Gilead Sciences, Inc.
Mar 6, 2025
Consulting Fee
Company’s description;4146837;VEM US;10018958
$2,850
Feb 28, 2025Viiv Healthcare Company
Feb 28, 2025
Travel and Lodging
travel to Chicago, IL · in-kind
$441
Feb 28, 2025Viiv Healthcare Company
Feb 28, 2025
Travel and Lodging
travel to Chicago, IL · in-kind
$31.02
Feb 24, 2025Merck Sharp & Dohme LLC
Feb 24, 2025
Consulting Fee$5,220
Feb 24, 2025Merck Sharp & Dohme LLC
Feb 24, 2025
Travel and Lodging
travel to Newark, NJ
$150
Feb 17, 2025Shionogi Inc
Feb 17, 2025
Compensation for services other than consulting (speaking, faculty)
S-217622 · Infections and Infectious Diseases
$3,182
Feb 11, 2025Merck Sharp & Dohme LLC
Feb 11, 2025
Travel and Lodging
INFECTIOUS DISEASE · travel to Elizabeth, NJ · in-kind
$144
Feb 11, 2025Merck Sharp & Dohme LLC
Feb 11, 2025
Travel and Lodging
INFECTIOUS DISEASE · travel to Elizabeth, NJ · in-kind
$120
Feb 10, 2025Merck Sharp & Dohme LLC
Feb 10, 2025
Travel and Lodging
INFECTIOUS DISEASE · travel to Elizabeth, NJ · in-kind
$213
Feb 10, 2025Merck Sharp & Dohme LLC
Feb 10, 2025
Travel and Lodging
INFECTIOUS DISEASE · travel to Elizabeth, NJ · in-kind
$207

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in North Carolina →

Industry-funded research

Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $3,780 in research payments for these studies, mostly to the institutions running them.

  • STUDY NAME#Demonstration of the feasibility of supported HCV treatment and eradication among persons with serious substance abuse disorders
    Merck Sharp & Dohme LLC

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Infectious Disease clinicians in Chapel Hill

Sources

NPI registry (CMS NPPES, November 2026; record last updated December 14, 2020), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1841239308. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.